Neuraxis (NRXS) CRO Thomas Carrico Receives RSU Award

What Happened

• Thomas J. Carrico, listed as CRO, CCO and CPO of Neuraxis, received a grant of 135,906 restricted stock units (RSUs) on Aug 13, 2026. The grant is reported at $6.28 per share for a reported grant value of $853,490. This was an award/compensation transaction (derivative), not an open-market purchase or sale.

Key Details

• Transaction date and reported value: Aug 13, 2026 — 135,906 RSUs at $6.28 each; total reported value $853,490.
• Filing date: Form 4 filed with the SEC on Aug 17, 2026 (reporting the Aug 13 grant).
• Shares owned after transaction: Not specified in the summary provided — see the full Form 4 for post-transaction holdings.
• Footnote: The RSUs were granted under the Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan. They vest in three equal annual installments over a three-year period.
• Transaction type: Derivative award (code A — grant/award/acquisition).

Context

• RSUs are a compensation grant that convert to common shares only as they vest; they don’t represent immediately tradable shares. Such grants are common for executive compensation and should be viewed as part of pay, not a direct market buy signal.
• For full details (exact ownership after vesting, any tax withholding, and timeliness), retail investors should review the complete Form 4 (Accession: 0001493152-26-038819).